Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Korman

Showing results (291-300 of 343) with videos related to

Pageof 35
Sort By:
American Journal of Infection Control|July 21, 2015
Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal serviceDavid M Lister, Despina Kotsanas, Susan A Ballard, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Journal of the American Academy of Dermatology|July 29, 2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosisBrian M Wei, Lindy P Fox, Benjamin H Kaffenberger, et al.
The Medical Journal of Australia|April 3, 2020
Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in AustraliaLeon Caly, Julian Druce, Jason Roberts, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.
Journal of the American Academy of Dermatology|July 29, 2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and managementBrian M Wei, Lindy P Fox, Benjamin H Kaffenberger, et al.
International Journal of Antimicrobial Agents|August 3, 2020
Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from AustraliaShakeel Mowlaboccus, Denise Daley, Stanley Pang, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2012
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and deathSharon C-A Chen, Monica A Slavin, Christopher H Heath, et al.
Pageof 35

Showing results (291-300 of 343) with videos related to

Sort By:
Pageof 35
American Journal of Infection Control|July 21, 2015
Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal serviceDavid M Lister, Despina Kotsanas, Susan A Ballard, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Journal of the American Academy of Dermatology|July 29, 2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosisBrian M Wei, Lindy P Fox, Benjamin H Kaffenberger, et al.
The Medical Journal of Australia|April 3, 2020
Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in AustraliaLeon Caly, Julian Druce, Jason Roberts, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.
Journal of the American Academy of Dermatology|July 29, 2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and managementBrian M Wei, Lindy P Fox, Benjamin H Kaffenberger, et al.
International Journal of Antimicrobial Agents|August 3, 2020
Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from AustraliaShakeel Mowlaboccus, Denise Daley, Stanley Pang, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2012
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and deathSharon C-A Chen, Monica A Slavin, Christopher H Heath, et al.
Pageof 35